{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:48:25Z","timestamp":1791830905066,"version":"4.3.4"},"reference-count":317,"publisher":"Portland Press Ltd.","issue":"2","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,6,1]]},"abstract":"<jats:p>Huntington's disease (HD) is a devastating autosomal dominant neurodegenerative disease caused by a CAG trinucleotide repeat expansion encoding an abnormally long polyglutamine tract in the huntingtin protein. Much has been learnt since the mutation was identified in 1993. We review the functions of wild-type huntingtin. Mutant huntingtin may cause toxicity via a range of different mechanisms. The primary consequence of the mutation is to confer a toxic gain of function on the mutant protein and this may be modified by certain normal activities that are impaired by the mutation. It is likely that the toxicity of mutant huntingtin is revealed after a series of cleavage events leading to the production of N-terminal huntingtin fragment(s) containing the expanded polyglutamine tract. Although aggregation of the mutant protein is a hallmark of the disease, the role of aggregation is complex and the arguments for protective roles of inclusions are discussed. Mutant huntingtin may mediate some of its toxicity in the nucleus by perturbing specific transcriptional pathways. HD may also inhibit mitochondrial function and proteasome activity. Importantly, not all of the effects of mutant huntingtin may be cell-autonomous, and it is possible that abnormalities in neighbouring neurons and glia may also have an impact on connected cells. It is likely that there is still much to learn about mutant huntingtin toxicity, and important insights have already come and may still come from chemical and genetic screens. Importantly, basic biological studies in HD have led to numerous potential therapeutic strategies.<\/jats:p>","DOI":"10.1042\/bj20071619","type":"journal-article","created":{"date-parts":[[2008,5,14]],"date-time":"2008-05-14T14:20:31Z","timestamp":1210774831000},"page":"191-209","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":346,"title":["Huntington's disease: from pathology and genetics to potential therapies"],"prefix":"10.1042","volume":"412","author":[{"given":"Sara","family":"Imarisio","sequence":"first","affiliation":[{"name":"Department of Medical Genetics, University of Cambridge, Cambridge Institute for Medical Research, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0XY, U.K."},{"name":"Department of Genetics, University of Cambridge, Cambridge CB2 3EH, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Carmichael","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, University of Cambridge, Cambridge Institute for Medical Research, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0XY, U.K."},{"name":"Department of Genetics, University of Cambridge, Cambridge CB2 3EH, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Korolchuk","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, University of Cambridge, Cambridge Institute for Medical Research, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0XY, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Wen","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, University of Cambridge, Cambridge Institute for Medical Research, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0XY, U.K."},{"name":"Department of Genetics, University of Cambridge, Cambridge CB2 3EH, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Saiki","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, University of Cambridge, Cambridge Institute for Medical Research, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0XY, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Rose","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, University of Cambridge, Cambridge Institute for Medical Research, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0XY, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gauri","family":"Krishna","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, University of Cambridge, Cambridge Institute for Medical Research, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0XY, U.K."},{"name":"Department of Genetics, University of Cambridge, Cambridge CB2 3EH, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet\u00a0E.","family":"Davies","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, University of Cambridge, Cambridge Institute for Medical Research, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0XY, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Ttofi","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, University of Cambridge, Cambridge Institute for Medical Research, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0XY, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin\u00a0R.","family":"Underwood","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, University of Cambridge, Cambridge Institute for Medical Research, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0XY, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David\u00a0C.","family":"Rubinsztein","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, University of Cambridge, Cambridge Institute for Medical Research, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0XY, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2008,5,14]]},"reference":[{"key":"2021112214193407900_B1","first-page":"320","article-title":"On Chorea","volume-title":"Medical and Surgical Reporter","author":"Huntington","year":"1872"},{"key":"2021112214193407900_B2","first-page":"312","article-title":"Practice of Medicine","author":"Water","year":"1842"},{"key":"2021112214193407900_B3","first-page":"47","article-title":"Discussion to Fritsch","volume":"4","author":"Meynert","year":"1877","journal-title":"Psychiatry"},{"key":"2021112214193407900_B4","first-page":"383","article-title":"Die anatomischen Veranderungen bei. Paralysis agitans und chronischer Chorea","volume":"2","author":"Jelgersma","year":"1907","journal-title":"Verh. Ges. Dtsch. Naturforsch. Aerzte"},{"key":"2021112214193407900_B5","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1212\/WNL.58.5.695","article-title":"Regional and progressive thinning of the cortical ribbon in Huntington's disease","volume":"58","author":"Rosas","year":"2002","journal-title":"Neurology"},{"key":"2021112214193407900_B6","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"The Huntington's Disease Collaborative Research Group","year":"1993","journal-title":"Cell"},{"key":"2021112214193407900_B7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1602\/neurorx.1.2.255","article-title":"Huntington's disease genetics","volume":"1","author":"Myers","year":"2004","journal-title":"NeuroRx"},{"key":"2021112214193407900_B8","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/hmg\/6.5.775","article-title":"Reduced penetrance of the Huntington's disease mutation","volume":"6","author":"McNeil","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"2021112214193407900_B9","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1136\/jmg.2006.045120","article-title":"Reduced penetrance alleles for Huntington's disease: a multi-centre direct observational study","volume":"44","author":"Quarrell","year":"2007","journal-title":"J. Med. Genet."},{"key":"2021112214193407900_B10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0896-6273(95)90138-8","article-title":"When more is less: pathogenesis of glutamine repeat neurodegenerative diseases","volume":"15","author":"Ross","year":"1995","journal-title":"Neuron"},{"key":"2021112214193407900_B11","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1073\/pnas.94.8.3872","article-title":"Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease","volume":"94","author":"Rubinsztein","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214193407900_B12","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1212\/WNL.53.6.1330","article-title":"Evidence for the GluR6 gene associated with younger onset age of Huntington's disease","volume":"53","author":"MacDonald","year":"1999","journal-title":"Neurology"},{"key":"2021112214193407900_B13","first-page":"108","article-title":"Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length","volume":"36","author":"Kehoe","year":"1999","journal-title":"J. Med. Genet."},{"key":"2021112214193407900_B14","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/ajmg.1400","article-title":"Familial influence on age of onset among siblings with Huntington disease","volume":"105","author":"Rosenblatt","year":"2001","journal-title":"Am. J. Med. Genet."},{"key":"2021112214193407900_B15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0304-3940(03)00436-1","article-title":"Modulation of age at onset in Huntington's disease and spinocerebellar ataxia type\u00a02 patients originated from eastern India","volume":"345","author":"Chattopadhyay","year":"2003","journal-title":"Neurosci. Lett."},{"key":"2021112214193407900_B16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neulet.2004.10.018","article-title":"Modulation of age at onset of Huntington disease patients by variations in TP53 and human caspase activated DNase (hCAD) genes","volume":"374","author":"Chattopadhyay","year":"2005","journal-title":"Neurosci. Lett."},{"key":"2021112214193407900_B17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10048-004-0175-2","article-title":"Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16","volume":"5","author":"Djousse","year":"2004","journal-title":"Neurogenetics"},{"key":"2021112214193407900_B18","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1073\/pnas.0308679101","article-title":"Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset","volume":"101","author":"Wexler","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214193407900_B19","first-page":"593","article-title":"Anticipation and instability of IT-15 (CAG)n repeats in parent-offspring pairs with Huntington disease","volume":"57","author":"Ranen","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"2021112214193407900_B20","first-page":"343","article-title":"Sex-dependent mechanisms for expansions and contractions of the CAG repeat on affected Huntington disease chromosomes","volume":"57","author":"Kremer","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"2021112214193407900_B21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/jmg.31.5.377","article-title":"Instability of CAG repeats in Huntington's disease: relation to parental transmission and age of onset","volume":"31","author":"Trottier","year":"1994","journal-title":"J. Med. Genet."},{"key":"2021112214193407900_B22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/35039051","article-title":"Molecular genetics: unmasking polyglutamine triggers in neurodegenerative disease","volume":"1","author":"Gusella","year":"2000","journal-title":"Nat. Rev. Neurosci."},{"key":"2021112214193407900_B23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.mad.2005.09.011","article-title":"Huntingtin fragmentation and increased caspase 3, 8 and 9 activities in lymphoblasts with heterozygous and homozygous Huntington's disease mutation","volume":"127","author":"Maglione","year":"2006","journal-title":"Mech. Ageing Dev."},{"key":"2021112214193407900_B24","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1093\/brain\/awg077","article-title":"Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course","volume":"126","author":"Squitieri","year":"2003","journal-title":"Brain"},{"key":"2021112214193407900_B25","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0968-0004(98)01350-4","article-title":"Glutamine repeats and neurodegenerative diseases: molecular aspects","volume":"24","author":"Perutz","year":"1999","journal-title":"Trends Biochem. Sci."},{"key":"2021112214193407900_B26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0168-9525(03)00074-X","article-title":"Transcriptional abnormalities in Huntington disease","volume":"19","author":"Sugars","year":"2003","journal-title":"Trends Genet."},{"key":"2021112214193407900_B27","first-page":"221","article-title":"New genes for old diseases: the molecular basis of myotonic dystrophy and Huntington's disease. The Lumleian Lecture 1995","volume":"30","author":"Harper","year":"1996","journal-title":"J. R. Coll. Phys. London"},{"key":"2021112214193407900_B28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF02257483","article-title":"Structure and expression of the Huntington's disease gene: evidence against simple inactivation due to an expanded CAG repeat","volume":"20","author":"Ambrose","year":"1994","journal-title":"Somat. Cell Mol. Genet."},{"key":"2021112214193407900_B29","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.7618107","article-title":"Inactivation of the mouse Huntington's disease gene homolog Hdh","volume":"269","author":"Duyao","year":"1995","journal-title":"Science"},{"key":"2021112214193407900_B30","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0092-8674(95)90542-1","article-title":"Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes","volume":"81","author":"Nasir","year":"1995","journal-title":"Cell"},{"key":"2021112214193407900_B31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ng1095-155","article-title":"Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue","volume":"11","author":"Zeitlin","year":"1995","journal-title":"Nat. Genet."},{"key":"2021112214193407900_B32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/hmg\/9.1.13","article-title":"Expanded polyglutamine peptides alone are intrinsically cytotoxic and cause neurodegeneration in Drosophila","volume":"9","author":"Marsh","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"2021112214193407900_B33","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0092-8674(00)80464-X","article-title":"Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse","volume":"91","author":"Ordway","year":"1997","journal-title":"Cell"},{"key":"2021112214193407900_B34","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0168-9525(01)02625-7","article-title":"Lessons from animal models of Huntington's disease","volume":"18","author":"Rubinsztein","year":"2002","journal-title":"Trends Genet."},{"key":"2021112214193407900_B35","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"},{"key":"2021112214193407900_B36"},{"key":"2021112214193407900_B37","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1074\/jbc.M103946200","article-title":"Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription","volume":"277","author":"Kegel","year":"2002","journal-title":"J. Biol. Chem."},{"key":"2021112214193407900_B38","doi-asserted-by":"crossref","first-page":"36464","DOI":"10.1074\/jbc.M503672200","article-title":"Huntingtin associates with acidic phospholipids at the plasma membrane","volume":"280","author":"Kegel","year":"2005","journal-title":"J. Biol. Chem."},{"key":"2021112214193407900_B39","doi-asserted-by":"crossref","first-page":"10045","DOI":"10.1073\/pnas.0610628104","article-title":"Huntingtin facilitates dynein\/dynactin-mediated vesicle transport","volume":"104","author":"Caviston","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214193407900_B40","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/hmg\/ddl467","article-title":"Wild-type huntingtin participates in protein trafficking between the Golgi and the extracellular space","volume":"16","author":"Strehlow","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"2021112214193407900_B41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/hmg\/ddl440","article-title":"The first 17 amino acids of huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis","volume":"16","author":"Rockabrand","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"2021112214193407900_B42","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1093\/hmg\/ddm217","article-title":"Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity","volume":"16","author":"Atwal","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"2021112214193407900_B43","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0968-0004(03)00168-3","article-title":"The hunt for huntingtin function: interaction partners tell many different stories","volume":"28","author":"Harjes","year":"2003","journal-title":"Trends Biochem. Sci."},{"key":"2021112214193407900_B44","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tig.2004.01.008","article-title":"Huntingtin-protein interactions and the pathogenesis of Huntington's disease","volume":"20","author":"Li","year":"2004","journal-title":"Trends Genet."},{"key":"2021112214193407900_B45","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/hmg\/ddi477","article-title":"Deletion of the triplet repeat encoding polyglutamine within the mouse Huntington's disease gene results in subtle behavioral\/motor phenotypes in vivo and elevated levels of ATP with cellular senescence in vitro","volume":"15","author":"Clabough","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"2021112214193407900_B46","doi-asserted-by":"crossref","first-page":"15916","DOI":"10.1074\/jbc.M511007200","article-title":"Expression and characterization of full-length human huntingtin, an elongated HEAT repeat protein","volume":"281","author":"Li","year":"2006","journal-title":"J. Biol. Chem."},{"key":"2021112214193407900_B47","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2202-3-15","article-title":"The predominantly HEAT-like motif structure of huntingtin and its association and coincident nuclear entry with dorsal, an NF-\u03baB\/Rel\/dorsal family transcription factor","volume":"3","author":"Takano","year":"2002","journal-title":"BMC Neurosci."},{"key":"2021112214193407900_B48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/jmbi.2001.4624","article-title":"Comparison of ARM and HEAT protein repeats","volume":"309","author":"Andrade","year":"2001","journal-title":"J. Mol. Biol."},{"key":"2021112214193407900_B49","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0092-8674(03)00033-3","article-title":"The ATRs, ATMs, and TORs are giant HEAT repeat proteins","volume":"112","author":"Perry","year":"2003","journal-title":"Cell"},{"key":"2021112214193407900_B50","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1101\/gr.147400","article-title":"HEAT repeats associated with condensins, cohesins, and other complexes involved in chromosome-related functions","volume":"10","author":"Neuwald","year":"2000","journal-title":"Genome Res."},{"key":"2021112214193407900_B51","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1093\/hmg\/ddg156","article-title":"Huntingtin contains a highly conserved nuclear export signal","volume":"12","author":"Xia","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"2021112214193407900_B52","first-page":"198","article-title":"Polyglutamine expansion of huntingtin impairs its nuclear export","volume":"37","author":"Cornett","year":"2005"},{"key":"2021112214193407900_B53","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bbamcr.2004.09.021","article-title":"SUMO protein modification","volume":"1695","author":"Dohmen","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"2021112214193407900_B54","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1126\/science.1092194","article-title":"SUMO modification of huntingtin and Huntington's disease pathology","volume":"304","author":"Steffan","year":"2004","journal-title":"Science"},{"key":"2021112214193407900_B55","doi-asserted-by":"crossref","first-page":"19385","DOI":"10.1074\/jbc.271.32.19385","article-title":"Huntingtin is ubiquitinated and interacts with a specific ubiquitin-conjugating enzyme","volume":"271","author":"Kalchman","year":"1996","journal-title":"J. Biol. Chem."},{"key":"2021112214193407900_B56","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.neuron.2004.11.027","article-title":"Huntingtin-interacting protein HIP14 is a palmitoyl transferase involved in palmitoylation and trafficking of multiple neuronal proteins","volume":"44","author":"Huang","year":"2004","journal-title":"Neuron"},{"key":"2021112214193407900_B57","first-page":"824","article-title":"Palmitoylation of huntingtin by HIP14 is essential for its trafficking and function","volume":"9","author":"Yanai","year":"2006"},{"key":"2021112214193407900_B58","doi-asserted-by":"crossref","first-page":"12784","DOI":"10.1073\/pnas.221451398","article-title":"Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis","volume":"98","author":"Kim","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214193407900_B59","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1523\/JNEUROSCI.22-12-04842.2002","article-title":"Calpain activation in Huntington's disease","volume":"22","author":"Gafni","year":"2002","journal-title":"J. Neurosci."},{"key":"2021112214193407900_B60","doi-asserted-by":"crossref","first-page":"7862","DOI":"10.1523\/JNEUROSCI.22-18-07862.2002","article-title":"Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease","volume":"22","author":"Wellington","year":"2002","journal-title":"J. Neurosci."},{"key":"2021112214193407900_B61","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1097-2765(02)00602-0","article-title":"Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions","volume":"10","author":"Lunkes","year":"2002","journal-title":"Mol. Cell"},{"key":"2021112214193407900_B62","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/sj.cdd.4401358","article-title":"Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease","volume":"11","author":"Hermel","year":"2004","journal-title":"Cell Death Differ."},{"key":"2021112214193407900_B63","doi-asserted-by":"crossref","first-page":"20211","DOI":"10.1074\/jbc.M401267200","article-title":"Inhibition of calpain cleavage of huntingtin reduces toxicity: accumulation of calpain\/caspase fragments in the nucleus","volume":"279","author":"Gafni","year":"2004","journal-title":"J. Biol. Chem."},{"key":"2021112214193407900_B64","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.cell.2006.04.026","article-title":"Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin","volume":"125","author":"Graham","year":"2006","journal-title":"Cell"},{"key":"2021112214193407900_B65","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1371\/journal.pgen.0030082","article-title":"Huntingtin interacting proteins are genetic modifiers of neurodegeneration","volume":"3","author":"Kaltenbach","year":"2007","journal-title":"PLoS Genet."},{"key":"2021112214193407900_B66","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1007\/s00018-006-6242-0","article-title":"Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies","volume":"63","author":"Borrell-Pages","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"2021112214193407900_B67","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/hmg\/ddm138","article-title":"Huntingtin-deficient zebrafish exhibit defects in iron utilization and development","volume":"16","author":"Lumsden","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"2021112214193407900_B68","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/81593","article-title":"Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice","volume":"26","author":"Dragatsis","year":"2000","journal-title":"Nat. Genet."},{"key":"2021112214193407900_B69","doi-asserted-by":"crossref","first-page":"14545","DOI":"10.1074\/jbc.C100044200","article-title":"Huntingtin's neuroprotective activity occurs via inhibition of procaspase-9 processing","volume":"276","author":"Rigamonti","year":"2001","journal-title":"J. Biol. Chem."},{"key":"2021112214193407900_B70","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/jmg.38.7.450","article-title":"Wild type huntingtin reduces the cellular toxicity of mutant huntingtin in mammalian cell models of Huntington's disease","volume":"38","author":"Ho","year":"2001","journal-title":"J. Med. Genet."},{"key":"2021112214193407900_B71","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1523\/JNEUROSCI.20-10-03705.2000","article-title":"Wild-type huntingtin protects from apoptosis upstream of caspase-3","volume":"20","author":"Rigamonti","year":"2000","journal-title":"J. Neurosci."},{"key":"2021112214193407900_B72","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/ncb735","article-title":"Recruitment and activation of caspase-8 by the huntingtin-interacting protein Hip-1 and a novel partner HIPPI","volume":"4","author":"Gervais","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"2021112214193407900_B73","doi-asserted-by":"crossref","first-page":"5896","DOI":"10.1038\/sj.emboj.7601445","article-title":"Huntingtin inhibits caspase-3 activation","volume":"25","author":"Zhang","year":"2006","journal-title":"EMBO J."},{"key":"2021112214193407900_B74","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/hmg\/7.9.1463","article-title":"Huntingtin interacts with a family of WW domain proteins","volume":"7","author":"Faber","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"2021112214193407900_B75","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.pneurobio.2006.11.004","article-title":"Nucleocytoplasmic trafficking and transcription effects of huntingtin in Huntington's disease","volume":"83","author":"Truant","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"2021112214193407900_B76","first-page":"76","article-title":"Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes","volume":"35","author":"Zuccato","year":"2003"},{"key":"2021112214193407900_B77","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1007\/s00018-005-5084-5","article-title":"Synaptic dysfunction in Huntington's disease: a new perspective","volume":"62","author":"Smith","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"key":"2021112214193407900_B78","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","article-title":"Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules","volume":"118","author":"Gauthier","year":"2004","journal-title":"Cell"},{"key":"2021112214193407900_B79","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0896-6273(03)00594-4","article-title":"Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila","volume":"40","author":"Gunawardena","year":"2003","journal-title":"Neuron"},{"key":"2021112214193407900_B80","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1083\/jcb.200509091","article-title":"Huntingtin\u2013HAP40 complex is a novel Rab5 effector that regulates early endosome motility and is up-regulated in Huntington's disease","volume":"172","author":"Pal","year":"2006","journal-title":"J. Cell Biol."},{"key":"2021112214193407900_B81","doi-asserted-by":"crossref","first-page":"8195","DOI":"10.1128\/MCB.24.18.8195-8209.2004","article-title":"Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro","volume":"24","author":"Trushina","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"2021112214193407900_B82","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1074\/jbc.M509806200","article-title":"Interaction of huntingtinassociated protein-1 with kinesin light chain: implications in intracellular trafficking in neurons","volume":"281","author":"McGuire","year":"2006","journal-title":"J. Biol. Chem."},{"key":"2021112214193407900_B83","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.pneurobio.2006.11.003","article-title":"N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease","volume":"81","author":"Fan","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"2021112214193407900_B84","doi-asserted-by":"crossref","first-page":"24713","DOI":"10.1074\/jbc.M103501200","article-title":"Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-D-aspartate receptors via post-synaptic density 95","volume":"276","author":"Sun","year":"2001","journal-title":"J. Biol. Chem."},{"key":"2021112214193407900_B85","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0896-6273(00)81008-9","article-title":"SynGAP: a synaptic RasGAP that associates with the PSD-95\/SAP90 protein family","volume":"20","author":"Kim","year":"1998","journal-title":"Neuron"},{"key":"2021112214193407900_B86","doi-asserted-by":"crossref","first-page":"34840","DOI":"10.1074\/jbc.M504508200","article-title":"Inhibition of metabotropic glutamate receptor signaling by the huntingtin-binding protein optineurin","volume":"280","author":"Anborgh","year":"2005","journal-title":"J. Biol. Chem."},{"key":"2021112214193407900_B87","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation","volume":"90","author":"Davies","year":"1997","journal-title":"Cell"},{"key":"2021112214193407900_B88","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","article-title":"Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin","volume":"8","author":"Schilling","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"2021112214193407900_B89","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/sj.mt.6300185","article-title":"Expression of mutated huntingtin fragment in the putamen is sufficient to produce abnormal movement in non-human primates","volume":"15","author":"Palfi","year":"2007","journal-title":"Mol. Ther."},{"key":"2021112214193407900_B90","doi-asserted-by":"crossref","first-page":"9158","DOI":"10.1074\/jbc.273.15.9158","article-title":"Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract","volume":"273","author":"Wellington","year":"1998","journal-title":"J. Biol. Chem."},{"key":"2021112214193407900_B91","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1083\/jcb.200412071","article-title":"Cdk5 phosphorylation of huntingtin reduces its cleavage by caspases: implications for mutant huntingtin toxicity","volume":"169","author":"Luo","year":"2005","journal-title":"J. Cell Biol."},{"key":"2021112214193407900_B92","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S1534-5807(02)00188-0","article-title":"The IGF-1\/Akt pathway is neuroprotective in Huntington's disease and involves huntingtin phosphorylation by Akt","volume":"2","author":"Humbert","year":"2002","journal-title":"Dev. Cell"},{"key":"2021112214193407900_B93","doi-asserted-by":"crossref","first-page":"23686","DOI":"10.1074\/jbc.M513507200","article-title":"Huntingtin phosphorylation sites mapped by mass spectrometry: modulation of cleavage and toxicity","volume":"281","author":"Schilling","year":"2006","journal-title":"J. Biol. Chem."},{"key":"2021112214193407900_B94","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.nbd.2005.07.014","article-title":"Progressive phenotype and nuclear accumulation of an amino-terminal cleavage fragment in a transgenic mouse model with inducible expression of full-length mutant huntingtin","volume":"21","author":"Tanaka","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"2021112214193407900_B95","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"2021112214193407900_B96","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1006\/nbdi.1998.0168","article-title":"Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length","volume":"4","author":"Becher","year":"1998","journal-title":"Neurobiol. Dis."},{"key":"2021112214193407900_B97","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1523\/JNEUROSCI.19-07-02522.1999","article-title":"Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology","volume":"19","author":"Gutekunst","year":"1999","journal-title":"J. Neurosci."},{"key":"2021112214193407900_B98","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1531-8249(199912)46:6<842::AID-ANA6>3.0.CO;2-O","article-title":"Huntington aggregates may not predict neuronal death in Huntington's disease","volume":"46","author":"Kuemmerle","year":"1999","journal-title":"Ann. Neurol."},{"key":"2021112214193407900_B99","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1083\/jcb.141.5.1097","article-title":"The influence of huntingtin protein size on nuclear localization and cellular toxicity","volume":"141","author":"Hackam","year":"1998","journal-title":"J. Cell Biol."},{"key":"2021112214193407900_B100","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1073\/pnas.97.6.2898","article-title":"Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington's disease","volume":"97","author":"Wyttenbach","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214193407900_B101","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/hmg\/7.9.1355","article-title":"A cellular model that recapitulates major pathogenic steps of Huntington's disease","volume":"7","author":"Lunkes","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"2021112214193407900_B102","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1023\/A:1010887421592","article-title":"Progressive formation of inclusions in the striatum and hippocampus of mice transgenic for the human Huntington's disease mutation","volume":"29","author":"Morton","year":"2000","journal-title":"J. Neurocytol."},{"key":"2021112214193407900_B103","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/ncb1477","article-title":"The chaperonin TRiC controls polyglutamine aggregation and toxicity through subunit-specific interactions","volume":"8","author":"Tam","year":"2006","journal-title":"Nat. Cell Biol."},{"key":"2021112214193407900_B104","doi-asserted-by":"crossref","first-page":"9267","DOI":"10.1523\/JNEUROSCI.22-21-09267.2002","article-title":"Purification of polyglutamine aggregates and identification of elongation factor-1\u03b1 and heat shock protein 84 as aggregate-interacting proteins","volume":"22","author":"Mitsui","year":"2002","journal-title":"J. Neurosci."},{"key":"2021112214193407900_B105","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/ncb1478","article-title":"Cytosolic chaperonin prevents polyglutamine toxicity with altering the aggregation state","volume":"8","author":"Kitamura","year":"2006","journal-title":"Nat. Cell Biol."},{"key":"2021112214193407900_B106","doi-asserted-by":"crossref","first-page":"11635","DOI":"10.1074\/jbc.M412042200","article-title":"Co-chaperone CHIP associates with expanded polyglutamine protein and promotes their degradation by proteasomes","volume":"280","author":"Jana","year":"2005","journal-title":"J. Biol. Chem."},{"key":"2021112214193407900_B107","doi-asserted-by":"crossref","first-page":"19831","DOI":"10.1074\/jbc.M109613200","article-title":"Characterization of a brain-enriched chaperone, MRJ, that inhibits huntingtin aggregation and toxicity independently","volume":"277","author":"Chuang","year":"2002","journal-title":"J. Biol. Chem."},{"key":"2021112214193407900_B108","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1093\/hmg\/9.13.2009","article-title":"Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity","volume":"9","author":"Jana","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"2021112214193407900_B109","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1093\/hmg\/ddi372","article-title":"Overexpression of yeast hsp104 reduces polyglutamine aggregation and prolongs survival of a transgenic mouse model of Huntington's disease","volume":"14","author":"Vacher","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"2021112214193407900_B110","doi-asserted-by":"crossref","first-page":"9701","DOI":"10.1073\/pnas.170280697","article-title":"Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cell models of Huntington's disease","volume":"97","author":"Carmichael","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214193407900_B111","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/hmg\/11.9.1137","article-title":"Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin","volume":"11","author":"Wyttenbach","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"2021112214193407900_B112","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.bbrc.2006.01.136","article-title":"Oxidative stress promotes mutant huntingtin aggregation and mutant huntingtin-dependent cell death by mimicking proteasomal malfunction","volume":"342","author":"Goswami","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021112214193407900_B113","doi-asserted-by":"crossref","first-page":"9195","DOI":"10.1074\/jbc.M607865200","article-title":"Identification of anti-prion compounds as efficient inhibitors of polyglutamine protein aggregation in a zebrafish model","volume":"282","author":"Schiffer","year":"2007","journal-title":"J. Biol. Chem."},{"key":"2021112214193407900_B114","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/sj.cdd.4401093","article-title":"\u2018Tissue\u2019 transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease","volume":"9","author":"Mastroberardino","year":"2002","journal-title":"Cell Death Differ."},{"key":"2021112214193407900_B115","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1523\/JNEUROSCI.5409-05.2006","article-title":"CA150 expression delays striatal cell death in overexpression and knock-in conditions for mutant huntingtin neurotoxicity","volume":"26","author":"Arango","year":"2006","journal-title":"J. Neurosci."},{"key":"2021112214193407900_B116","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1073\/pnas.0511256103","article-title":"Pharmacological promotion of inclusion formation: a therapeutic approach for Huntington's and Parkinson's diseases","volume":"103","author":"Bodner","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214193407900_B117","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","article-title":"Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death","volume":"431","author":"Arrasate","year":"2004","journal-title":"Nature"},{"key":"2021112214193407900_B118","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/ng0298-150","article-title":"Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates","volume":"18","author":"Martindale","year":"1998","journal-title":"Nat. Genet."},{"key":"2021112214193407900_B119","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0092-8674(00)81782-1","article-title":"Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions","volume":"95","author":"Saudou","year":"1998","journal-title":"Cell"},{"key":"2021112214193407900_B120","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/nm1066","article-title":"Protein aggregation and neurodegenerative disease","volume":"10","author":"Ross","year":"2004","journal-title":"Nat. Med."},{"key":"2021112214193407900_B121","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/hmg\/ddh175","article-title":"Nuclear-targeting of mutant huntingtin fragments produces Huntington's disease-like phenotypes in transgenic mice","volume":"13","author":"Schilling","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"2021112214193407900_B122","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.1073\/pnas.91.12.5355","article-title":"Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases","volume":"91","author":"Perutz","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214193407900_B123","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1126\/science.8303297","article-title":"Transcriptional activation modulated by homopolymeric glutamine and proline stretches","volume":"263","author":"Gerber","year":"1994","journal-title":"Science"},{"key":"2021112214193407900_B124","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1073\/pnas.96.20.11404","article-title":"Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells","volume":"96","author":"Kazantsev","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214193407900_B125","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1126\/science.1056784","article-title":"Interference by huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity","volume":"291","author":"Nucifora","year":"2001","journal-title":"Science"},{"key":"2021112214193407900_B126","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","article-title":"The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription","volume":"97","author":"Steffan","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214193407900_B127","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","article-title":"Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila","volume":"413","author":"Steffan","year":"2001","journal-title":"Nature"},{"key":"2021112214193407900_B128","doi-asserted-by":"crossref","first-page":"15179","DOI":"10.1073\/pnas.261400698","article-title":"Histone deacetylase inhibitors reduce polyglutamine toxicity","volume":"98","author":"McCampbell","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214193407900_B129","doi-asserted-by":"crossref","first-page":"13201","DOI":"10.1073\/pnas.191498198","article-title":"Altered transcription in yeast expressing expanded polyglutamine","volume":"98","author":"Hughes","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214193407900_B130","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","article-title":"Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice","volume":"23","author":"Ferrante","year":"2003","journal-title":"J. Neurosci."},{"key":"2021112214193407900_B131","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1073\/pnas.0437870100","article-title":"Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease","volume":"100","author":"Hockly","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214193407900_B132","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1101\/SQB.1993.058.01.022","article-title":"Coactivators and TAFs: a new class of eukaryotic transcription factors that connect activators to the basal machinery","volume":"58","author":"Tanese","year":"1993","journal-title":"Cold Spring Harbor Symp. Quant. Biol."},{"key":"2021112214193407900_B133","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/hmg\/11.8.905","article-title":"Huntingtin inclusions do not deplete polyglutamine-containing transcription factors in HD mice","volume":"11","author":"Yu","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"2021112214193407900_B134","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1126\/science.1072613","article-title":"Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease","volume":"296","author":"Dunah","year":"2002","journal-title":"Science"},{"key":"2021112214193407900_B135","doi-asserted-by":"crossref","first-page":"16672","DOI":"10.1074\/jbc.M511648200","article-title":"Sp1 is up-regulated in cellular and transgenic models of Huntington disease, and its reduction is neuroprotective","volume":"281","author":"Qiu","year":"2006","journal-title":"J. Biol. Chem."},{"key":"2021112214193407900_B136","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.cell.2005.10.030","article-title":"In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets","volume":"123","author":"Zhai","year":"2005","journal-title":"Cell"},{"key":"2021112214193407900_B137","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","article-title":"A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration","volume":"23","author":"Hodgson","year":"1999","journal-title":"Neuron"},{"key":"2021112214193407900_B138","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0092-8674(95)90298-8","article-title":"REST: a mammalian silencer protein that restricts sodium channel gene expression to neurons","volume":"80","author":"Chong","year":"1995","journal-title":"Cell"},{"key":"2021112214193407900_B139"},{"key":"2021112214193407900_B140","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1126\/science.7871435","article-title":"The neuron-restrictive silencer factor (NRSF): a coordinate repressor of multiple neuron-specific genes","volume":"267","author":"Schoenherr","year":"1995","journal-title":"Science"},{"key":"2021112214193407900_B141","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0092-8674(00)81410-5","article-title":"A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis","volume":"92","author":"Puigserver","year":"1998","journal-title":"Cell"},{"key":"2021112214193407900_B142","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1210\/er.2002-0012","article-title":"Peroxisome proliferator activated receptor-\u03b3 coactivator 1\u03b1 (PGC-1\u03b1): transcriptional coactivator and metabolic regulator","volume":"24","author":"Puigserver","year":"2003","journal-title":"Endocr. Rev."},{"key":"2021112214193407900_B143","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nature00904","article-title":"Transcriptional co-activator PGC-1\u03b1 drives the formation of slow-twitch muscle fibres","volume":"418","author":"Lin","year":"2002","journal-title":"Nature"},{"key":"2021112214193407900_B144","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1371\/journal.pbio.0030101","article-title":"PGC-1\u03b1 deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis","volume":"3","author":"Leone","year":"2005","journal-title":"PLoS Biol."},{"key":"2021112214193407900_B145","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1\u03b1 by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"key":"2021112214193407900_B146","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cmet.2006.10.004","article-title":"Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1\u03b1 in Huntington's disease neurodegeneration","volume":"4","author":"Weydt","year":"2006","journal-title":"Cell Metab."},{"key":"2021112214193407900_B147","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.neuroscience.2006.10.056","article-title":"Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases","volume":"145","author":"Trushina","year":"2007","journal-title":"Neuroscience"},{"key":"2021112214193407900_B148","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"key":"2021112214193407900_B149","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/ana.20624","article-title":"Mitochondria take center stage in aging and neurodegeneration","volume":"58","author":"Beal","year":"2005","journal-title":"Ann. Neurol."},{"key":"2021112214193407900_B150","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0968-0004(00)01674-1","article-title":"Mitochondria, oxygen free radicals, disease and ageing","volume":"25","author":"Raha","year":"2000","journal-title":"Trends Biochem. Sci."},{"key":"2021112214193407900_B151","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1152\/physrev.1979.59.3.527","article-title":"Hydroperoxide metabolism in mammalian organs","volume":"59","author":"Chance","year":"1979","journal-title":"Physiol. Rev."},{"key":"2021112214193407900_B152","doi-asserted-by":"crossref","first-page":"26699","DOI":"10.1016\/S0021-9258(19)74369-5","article-title":"Absence of electron transport (Rho 0 state) restores growth of a manganese superoxide dismutase-deficient Saccharomyces cerevisiae in hyperoxia: evidence for electron transport as a major source of superoxide generation in vivo","volume":"268","author":"Guidot","year":"1993","journal-title":"J. Biol. Chem."},{"key":"2021112214193407900_B153","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1002\/ana.410320706","article-title":"Free radical damage to protein and DNA: mechanisms involved and relevant observations on brain undergoing oxidative stress","volume":"32","author":"Floyd","year":"1992","journal-title":"Ann. Neurol."},{"key":"2021112214193407900_B154","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/10715769309145868","article-title":"The reaction of NO with superoxide","volume":"18","author":"Huie","year":"1993","journal-title":"Free Radical Res. Commun."},{"key":"2021112214193407900_B155","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/abbi.1994.1013","article-title":"Inhibition of mitochondrial electron transport by peroxynitrite","volume":"308","author":"Radi","year":"1994","journal-title":"Arch. Biochem. Biophys."},{"key":"2021112214193407900_B156","doi-asserted-by":"crossref","first-page":"29409","DOI":"10.1016\/S0021-9258(18)43894-X","article-title":"Aconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide","volume":"269","author":"Castro","year":"1994","journal-title":"J. Biol. Chem."},{"key":"2021112214193407900_B157","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1021\/bi971894b","article-title":"Peroxynitrite-mediated inactivation of manganese superoxide dismutase involves nitration and oxidation of critical tyrosine residues","volume":"37","author":"MacMillan-Crow","year":"1998","journal-title":"Biochemistry"},{"key":"2021112214193407900_B158","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.micro.57.030502.090938","article-title":"Pathways of oxidative damage","volume":"57","author":"Imlay","year":"2003","journal-title":"Annu. Rev. Microbiol."},{"key":"2021112214193407900_B159","doi-asserted-by":"crossref","first-page":"13399","DOI":"10.1074\/jbc.270.22.13399","article-title":"Superoxide radical and iron modulate aconitase activity in mammalian cells","volume":"270","author":"Gardner","year":"1995","journal-title":"J. Biol. Chem."},{"key":"2021112214193407900_B160","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cell.2005.02.001","article-title":"Mitochondria, oxidants, and aging","volume":"120","author":"Balaban","year":"2005","journal-title":"Cell"},{"key":"2021112214193407900_B161","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0955-0674(03)00002-4","article-title":"Oxidant signals and oxidative stress","volume":"15","author":"Finkel","year":"2003","journal-title":"Curr. Opin. Cell Biol."},{"key":"2021112214193407900_B162","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0891-5849(02)00856-0","article-title":"Role of oxidative stress and protein oxidation in the aging process","volume":"33","author":"Sohal","year":"2002","journal-title":"Free Radical Biol. Med."},{"key":"2021112214193407900_B163","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1023\/B:NERE.0000014824.04728.dd","article-title":"The energetics of Huntington's disease","volume":"29","author":"Browne","year":"2004","journal-title":"Neurochem. Res."},{"key":"2021112214193407900_B164","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E","article-title":"Biochemical abnormalities and excitotoxicity in Huntington's disease brain","volume":"45","author":"Tabrizi","year":"1999","journal-title":"Ann. Neurol."},{"key":"2021112214193407900_B165","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"2021112214193407900_B166","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/mds.20373","article-title":"Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease","volume":"20","author":"Saft","year":"2005","journal-title":"Mov. Disord."},{"key":"2021112214193407900_B167","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ajmg.1425","article-title":"Mitochondria and degenerative disorders","volume":"106","author":"Orth","year":"2001","journal-title":"Am. J. Med. Genet."},{"key":"2021112214193407900_B168","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/hmg\/ddh162","article-title":"Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release","volume":"13","author":"Choo","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"2021112214193407900_B169","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0003-9861(02)00585-4","article-title":"In vitro effects of polyglutamine tracts on Ca2+-dependent depolarization of rat and human mitochondria: relevance to Huntington's disease","volume":"410","author":"Panov","year":"2003","journal-title":"Arch. Biochem. Biophys."},{"key":"2021112214193407900_B170","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","article-title":"Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines","volume":"5","author":"Panov","year":"2002","journal-title":"Nat. Neurosci."},{"key":"2021112214193407900_B171","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/13518","article-title":"Increased apoptosis of Huntington disease lymphoblasts associated with repeat length dependent mitochondrial depolarization","volume":"5","author":"Sawa","year":"1999","journal-title":"Nat. Med."},{"key":"2021112214193407900_B172","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0968-0004(03)00053-7","article-title":"Historical review: mitochondria and calcium: ups and downs of an unusual relationship","volume":"28","author":"Carafoli","year":"2003","journal-title":"Trends Biochem. Sci."},{"key":"2021112214193407900_B173","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nrm1150","article-title":"Regulation of cell death: the calcium\u2013apoptosis link","volume":"4","author":"Orrenius","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2021112214193407900_B174","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1093\/hmg\/ddi319","article-title":"HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism","volume":"14","author":"Seong","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"2021112214193407900_B175","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0006-8993(88)90765-2","article-title":"Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced","volume":"451","author":"Novelli","year":"1988","journal-title":"Brain Res."},{"key":"2021112214193407900_B176","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0079-6123(08)61152-8","article-title":"The role of free radicals in NMDA-dependent neurotoxicity","volume":"103","author":"Fagni","year":"1994","journal-title":"Prog. Brain Res."},{"key":"2021112214193407900_B177","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.mcn.2003.11.014","article-title":"Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington's disease","volume":"25","author":"Zeron","year":"2004","journal-title":"Mol. Cell. Neurosci."},{"key":"2021112214193407900_B178","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0896-6273(02)00615-3","article-title":"Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease","volume":"33","author":"Zeron","year":"2002","journal-title":"Neuron"},{"key":"2021112214193407900_B179","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/364535a0","article-title":"NMDA-dependent superoxide production and neurotoxicity","volume":"364","author":"Lafon-Cazal","year":"1993","journal-title":"Nature"},{"key":"2021112214193407900_B180","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1523\/JNEUROSCI.15-05-03318.1995","article-title":"Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation","volume":"15","author":"Reynolds","year":"1995","journal-title":"J. Neurosci."},{"key":"2021112214193407900_B181","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1042\/bst0250944","article-title":"Potential mechanisms for nitric oxide-mediated impairment of brain mitochondrial energy metabolism","volume":"25","author":"Bolanos","year":"1997","journal-title":"Biochem. Soc. Trans."},{"key":"2021112214193407900_B182","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0006-8993(00)02082-5","article-title":"Striatal oxidative damage parallels the expression of a neurological phenotype in mice transgenic for the mutation of Huntington's disease","volume":"862","author":"Perez-Severiano","year":"2000","journal-title":"Brain Res."},{"key":"2021112214193407900_B183","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/j.1471-4159.2006.03907.x","article-title":"Oxidative stress and neurodegeneration: where are we now?","volume":"97","author":"Halliwell","year":"2006","journal-title":"J. Neurochem."},{"key":"2021112214193407900_B184","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.freeradbiomed.2004.11.032","article-title":"The powerhouse takes control of the cell: is the mitochondrial permeability transition a viable therapeutic target against neuronal dysfunction and death?","volume":"38","author":"Stavrovskaya","year":"2005","journal-title":"Free Radical Biol. Med."},{"key":"2021112214193407900_B185","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.nbd.2005.12.007","article-title":"Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons","volume":"22","author":"Chang","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"2021112214193407900_B186","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/35072063","article-title":"The genetics and pathology of oxidative phosphorylation","volume":"2","author":"Smeitink","year":"2001","journal-title":"Nat. Rev. Genet."},{"key":"2021112214193407900_B187","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0304-3940(99)00578-9","article-title":"Oxidative damage to mitochondrial DNA in Huntington's disease parietal cortex","volume":"272","author":"Polidori","year":"1999","journal-title":"Neurosci. Lett."},{"key":"2021112214193407900_B188","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1046\/j.1471-4159.2001.00689.x","article-title":"Increased oxidative damage to DNA in a transgenic mouse model of Huntington's disease","volume":"79","author":"Bogdanov","year":"2001","journal-title":"J. Neurochem."},{"key":"2021112214193407900_B189","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.410410514","article-title":"Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia","volume":"41","author":"Browne","year":"1997","journal-title":"Ann. Neurol."},{"key":"2021112214193407900_B190","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nrg1606","article-title":"Mitochondrial DNA mutations in human disease","volume":"6","author":"Taylor","year":"2005","journal-title":"Nat. Rev. Genet."},{"key":"2021112214193407900_B191","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1196\/annals.1293.014","article-title":"Mitochondrial DNA mutation and depletion increase the susceptibility of human cells to apoptosis","volume":"1011","author":"Liu","year":"2004","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"2021112214193407900_B192","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1073\/pnas.87.12.4533","article-title":"Oxidative damage to DNA during aging: 8-hydroxy-2\u2032-deoxyguanosine in rat organ DNA and urine","volume":"87","author":"Fraga","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214193407900_B193","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nature05778","article-title":"OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells","volume":"447","author":"Kovtun","year":"2007","journal-title":"Nature"},{"key":"2021112214193407900_B194","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/hmg\/ddm057","article-title":"Hsp27 overexpression in the R6\/2 mouse model of Huntington's disease: chronic neurodegeneration does not induce Hsp27 activation","volume":"16","author":"Zourlidou","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"2021112214193407900_B195","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1074\/mcp.M500090-MCP200","article-title":"Proteomic analysis of protein expression and oxidative modification in r6\/2 transgenic mice: a model of Huntington disease","volume":"4","author":"Perluigi","year":"2005","journal-title":"Mol. Cell. Proteomics"},{"key":"2021112214193407900_B196","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0098-2997(02)00017-1","article-title":"Biomarkers","volume":"23","author":"Griffiths","year":"2002","journal-title":"Mol. Aspects Med."},{"key":"2021112214193407900_B197","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.nbd.2004.12.009","article-title":"Mitochondrial associated metabolic proteins are selectively oxidized in A30P \u03b1-synuclein transgenic mice: a model of familial Parkinson's disease","volume":"18","author":"Poon","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"2021112214193407900_B198","first-page":"91","article-title":"Cytoskeletal oxidative changes lead to alterations of specific cell surface receptors","volume":"38","author":"Malorni","year":"1994","journal-title":"Eur. J. Histochem."},{"key":"2021112214193407900_B199","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1126\/science.292.5521.1552","article-title":"Impairment of the ubiquitin\u2013proteasome system by protein aggregation","volume":"292","author":"Bence","year":"2001","journal-title":"Science"},{"key":"2021112214193407900_B200","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/hmg\/10.10.1049","article-title":"Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release","volume":"10","author":"Jana","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"2021112214193407900_B201","doi-asserted-by":"crossref","first-page":"13935","DOI":"10.1074\/jbc.M107706200","article-title":"Polyglutamine expansion, protein aggregation, proteasome activity, and neural survival","volume":"277","author":"Ding","year":"2002","journal-title":"J. Biol. Chem."},{"key":"2021112214193407900_B202","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/hmg\/ddi064","article-title":"Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin\u2013proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation","volume":"14","author":"Bowman","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"2021112214193407900_B203","doi-asserted-by":"crossref","first-page":"11653","DOI":"10.1523\/JNEUROSCI.23-37-11653.2003","article-title":"Neuronal induction of the immunoproteasome in Huntington's disease","volume":"23","author":"Diaz-Hernandez","year":"2003","journal-title":"J. Neurosci."},{"key":"2021112214193407900_B204","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/hmg\/ddi423","article-title":"Proteasome impairment does not contribute to pathogenesis in R6\/2 Huntington's disease mice: exclusion of proteasome activator REG\u03b3 as a therapeutic target","volume":"15","author":"Bett","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"2021112214193407900_B205","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nature02263","article-title":"Protein degradation and protection against misfolded or damaged proteins","volume":"426","author":"Goldberg","year":"2003","journal-title":"Nature"},{"key":"2021112214193407900_B206","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1212\/01.wnl.0000192261.02023.b8","article-title":"The ubiquitin proteolytic system: from a vague idea, through basic mechanisms, and onto human diseases and drug targeting","volume":"66","author":"Ciechanover","year":"2006","journal-title":"Neurology"},{"key":"2021112214193407900_B207","doi-asserted-by":"crossref","first-page":"22123","DOI":"10.1074\/jbc.274.32.22123","article-title":"The proteasome, a novel protease regulated by multiple mechanisms","volume":"274","author":"DeMartino","year":"1999","journal-title":"J. Biol. Chem."},{"key":"2021112214193407900_B208","doi-asserted-by":"crossref","first-page":"20878","DOI":"10.1016\/S0021-9258(17)31904-X","article-title":"PA700, an ATP-dependent activator of the 20 S proteasome, is an ATPase containing multiple members of a nucleotide-binding protein family","volume":"269","author":"DeMartino","year":"1994","journal-title":"J. Biol. Chem."},{"key":"2021112214193407900_B209","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.biochem.67.1.425","article-title":"The ubiquitin system","volume":"67","author":"Hershko","year":"1998","journal-title":"Annu. Rev. Biochem."},{"key":"2021112214193407900_B210","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0161-5890(02)00098-6","article-title":"The importance of the proteasome and subsequent proteolytic steps in the generation of antigenic peptides","volume":"39","author":"Goldberg","year":"2002","journal-title":"Mol. Immunol."},{"key":"2021112214193407900_B211","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.tibs.2004.10.008","article-title":"Rad23 and Rpn10: perennial wallflowers join the melee","volume":"29","author":"Madura","year":"2004","journal-title":"Trends Biochem. Sci."},{"key":"2021112214193407900_B212","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1002\/j.1460-2075.1994.tb06625.x","article-title":"Displacement of housekeeping proteasome subunits by MHC-encoded LMPs: a newly discovered mechanism for modulating the multicatalytic proteinase complex","volume":"13","author":"Fruh","year":"1994","journal-title":"EMBO J."},{"key":"2021112214193407900_B213","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature04769","article-title":"Activity-dependent dynamics and sequestration of proteasomes in dendritic spines","volume":"441","author":"Bingol","year":"2006","journal-title":"Nature"},{"key":"2021112214193407900_B214","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/502","article-title":"Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1","volume":"19","author":"Cummings","year":"1998","journal-title":"Nat. Genet."},{"key":"2021112214193407900_B215","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.molcel.2004.12.021","article-title":"Global impairment of the ubiquitin\u2013proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation","volume":"17","author":"Bennett","year":"2005","journal-title":"Mol. Cell"},{"key":"2021112214193407900_B216","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/ncb863","article-title":"Polyglutamine protein aggregates are dynamic","volume":"4","author":"Kim","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"2021112214193407900_B217","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1038\/sj.emboj.7600426","article-title":"Inefficient degradation of truncated polyglutamine proteins by the proteasome","volume":"23","author":"Holmberg","year":"2004","journal-title":"EMBO J."},{"key":"2021112214193407900_B218","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1097-2765(04)00151-0","article-title":"Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins","volume":"14","author":"Venkatraman","year":"2004","journal-title":"Mol. Cell"},{"key":"2021112214193407900_B219","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/j.1471-4159.2006.03968.x","article-title":"Inhibition of 26S proteasome activity by huntingtin filaments but not inclusion bodies isolated from mouse and human brain","volume":"98","author":"Diaz-Hernandez","year":"2006","journal-title":"J. Neurochem."},{"key":"2021112214193407900_B220","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ana.20207","article-title":"Generalized brain and skin proteasome inhibition in Huntington's disease","volume":"56","author":"Seo","year":"2004","journal-title":"Ann. Neurol."},{"key":"2021112214193407900_B221","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1371\/journal.pone.0000238","article-title":"Proteasome activator enhances survival of huntington's disease neuronal model cells","volume":"2","author":"Seo","year":"2007","journal-title":"PLoS ONE"},{"key":"2021112214193407900_B222","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-3-7091-0579-5_14","article-title":"The N-methyl-D-aspartate antagonist memantine retards progression of Huntington's disease","volume":"68","author":"Beister","year":"2004","journal-title":"J. Neural Transm. Suppl."},{"key":"2021112214193407900_B223","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng1362","article-title":"Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease","volume":"36","author":"Ravikumar","year":"2004","journal-title":"Nat. Genet."},{"key":"2021112214193407900_B224","doi-asserted-by":"crossref","first-page":"22044","DOI":"10.1074\/jbc.M212235200","article-title":"Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function","volume":"278","author":"Tsai","year":"2003","journal-title":"J. Biol. Chem."},{"key":"2021112214193407900_B225","doi-asserted-by":"crossref","first-page":"8772","DOI":"10.1523\/JNEUROSCI.21-22-08772.2001","article-title":"Proteasomal-dependent aggregate reversal and absence of cell death in a conditional mouse model of Huntington's disease","volume":"21","author":"Martin-Aparicio","year":"2001","journal-title":"J. Neurosci."},{"key":"2021112214193407900_B226","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1091\/mbc.12.5.1393","article-title":"Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation","volume":"12","author":"Waelter","year":"2001","journal-title":"Mol. Biol. Cell"},{"key":"2021112214193407900_B227","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/hmg\/11.9.1107","article-title":"Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy","volume":"11","author":"Ravikumar","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"2021112214193407900_B228","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/sj.emboj.7601592","article-title":"Puromycin-sensitive aminopeptidase is the major peptidase responsible for digesting polyglutamine sequences released by proteasomes during protein degradation","volume":"26","author":"Bhutani","year":"2007","journal-title":"EMBO J."},{"key":"2021112214193407900_B229","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature01301","article-title":"Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders","volume":"421","author":"Sanchez","year":"2003","journal-title":"Nature"},{"key":"2021112214193407900_B230","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/hmg\/ddi422","article-title":"Trehalose reduces aggregate formation and delays pathology in a transgenic mouse model of oculopharyngeal muscular dystrophy","volume":"15","author":"Davies","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"2021112214193407900_B231","doi-asserted-by":"crossref","first-page":"15916","DOI":"10.1074\/jbc.M511007200","article-title":"Expression and characterization of full-length human huntingtin, an elongated HEAT repeat protein","volume":"281","author":"Li","year":"2006","journal-title":"J. Biol. Chem."},{"key":"2021112214193407900_B232","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1523\/JNEUROSCI.23-03-00961.2003","article-title":"Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease","volume":"23","author":"Cepeda","year":"2003","journal-title":"J. Neurosci."},{"key":"2021112214193407900_B233","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/ana.410430506","article-title":"Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: implications for ischemia and Huntington's disease","volume":"43","author":"Calabresi","year":"1998","journal-title":"Ann. Neurol."},{"key":"2021112214193407900_B234","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/(SICI)1096-9861(20000417)419:4<407::AID-CNE1>3.0.CO;2-I","article-title":"Expression of NMDA receptor subunit mRNAs in neurochemically identified projection and interneurons in the human striatum","volume":"419","author":"Kuppenbender","year":"2000","journal-title":"J. Comp. Neurol."},{"key":"2021112214193407900_B235","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/archneur.58.3.365","article-title":"Glutamate transporters in neurologic disease","volume":"58","author":"Maragakis","year":"2001","journal-title":"Arch. Neurol."},{"key":"2021112214193407900_B236","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1006\/nbdi.2001.0430","article-title":"Impaired glutamate uptake in the R6 Huntington's disease transgenic mice","volume":"8","author":"Lievens","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"2021112214193407900_B237","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/brain\/awf180","article-title":"Impaired glutamate transport and glutamate\u2013glutamine cycling: downstream effects of the Huntington mutation","volume":"125","author":"Behrens","year":"2002","journal-title":"Brain"},{"key":"2021112214193407900_B238","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.pneurobio.2006.12.005","article-title":"Functions, dysfunctions and possible therapeutic relevance of adenosine A2A receptors in Huntington's disease","volume":"81","author":"Popoli","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"2021112214193407900_B239","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1083\/jcb.200508072","article-title":"Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity","volume":"171","author":"Shin","year":"2005","journal-title":"J. Cell Biol."},{"key":"2021112214193407900_B240","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.neuron.2005.03.025","article-title":"Pathological cell\u2013cell interactions elicited by a neuropathogenic form of mutant huntingtin contribute to cortical pathogenesis in HD mice","volume":"46","author":"Gu","year":"2005","journal-title":"Neuron"},{"key":"2021112214193407900_B241","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/378398a0","article-title":"A huntingtin-associated protein enriched in brain with implications for pathology","volume":"378","author":"Li","year":"1995","journal-title":"Nature"},{"key":"2021112214193407900_B242","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/ng0597-44","article-title":"HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane associated huntingtin in the brain","volume":"16","author":"Kalchman","year":"1997","journal-title":"Nat. Genet."},{"key":"2021112214193407900_B243","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/hmg\/6.3.487","article-title":"HIP-I: a huntingtin interacting protein isolated by the yeast two-hybrid system","volume":"6","author":"Wanker","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"2021112214193407900_B244","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/hmg\/7.3.371","article-title":"Huntingtin interacts with cystathionine \u03b2-synthase","volume":"7","author":"Boutell","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"2021112214193407900_B245","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/hmg\/7.9.1463","article-title":"Huntingtin interacts with a family of WW domain proteins","volume":"7","author":"Faber","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"2021112214193407900_B246","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1073\/pnas.0437967100","article-title":"Cdc42-interacting protein 4 binds to huntingtin: neuropathologic and biological evidence for a role in Huntington's disease","volume":"100","author":"Holbert","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214193407900_B247","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1073\/pnas.98.4.1811","article-title":"The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis","volume":"98","author":"Holbert","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214193407900_B248","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.molcel.2004.09.016","article-title":"A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease","volume":"15","author":"Goehler","year":"2004","journal-title":"Mol. Cell"},{"key":"2021112214193407900_B249","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1371\/journal.pgen.0030082","article-title":"Huntingtin interacting proteins are genetic modifiers of neurodegeneration","volume":"3","author":"Kaltenbach","year":"2007","journal-title":"PLoS Genet."},{"key":"2021112214193407900_B250","doi-asserted-by":"crossref","first-page":"16400","DOI":"10.1073\/pnas.182426599","article-title":"Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington's disease by using an automated filter retardation assay","volume":"99","author":"Heiser","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214193407900_B251","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/1087057107299428","article-title":"Discovery of a novel small-molecule targeting selective clearance of mutant huntingtin fragments","volume":"12","author":"Coufal","year":"2007","journal-title":"J. Biomol. Screen."},{"key":"2021112214193407900_B252","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1083\/jcb.200510065","article-title":"Autophagymediated clearance of huntingtin aggregates triggered by the insulin-signaling pathway","volume":"172","author":"Yamamoto","year":"2006","journal-title":"J. Cell Biol."},{"key":"2021112214193407900_B253","doi-asserted-by":"crossref","first-page":"6403","DOI":"10.1073\/pnas.0307697101","article-title":"Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation","volume":"101","author":"Nollen","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214193407900_B254","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.nbd.2004.04.001","article-title":"A cell-based screen for drugs to treat Huntington's disease","volume":"16","author":"Aiken","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"2021112214193407900_B255","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/hmg\/ddh045","article-title":"A screen for drugs that protect against the cytotoxicity of polyglutamine-expanded androgen receptor","volume":"13","author":"Piccioni","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"2021112214193407900_B256","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/ng1542","article-title":"A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease","volume":"37","author":"Giorgini","year":"2005","journal-title":"Nat. Genet."},{"key":"2021112214193407900_B257","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1126\/science.1090389","article-title":"Yeast genes that enhance the toxicity of a mutant huntingtin fragment or \u03b1-synuclein","volume":"302","author":"Willingham","year":"2003","journal-title":"Science"},{"key":"2021112214193407900_B258","doi-asserted-by":"crossref","first-page":"17131","DOI":"10.1073\/pnas.262544899","article-title":"Glutamine\/proline-rich PQE-1 proteins protect Caenorhabditis elegans neurons from huntingtin polyglutamine neurotoxicity","volume":"99","author":"Faber","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214193407900_B259","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1126\/science.287.5459.1837","article-title":"Genetic suppression of polyglutamine toxicity in Drosophila","volume":"287","author":"Kazemi-Esfarjani","year":"2000","journal-title":"Science"},{"key":"2021112214193407900_B260","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0896-6273(00)80573-5","article-title":"Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons","volume":"21","author":"Jackson","year":"1998","journal-title":"Neuron"},{"key":"2021112214193407900_B261","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/70532","article-title":"Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70","volume":"23","author":"Warrick","year":"1999","journal-title":"Nat. Genet."},{"key":"2021112214193407900_B262","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0092-8674(00)81200-3","article-title":"Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila","volume":"93","author":"Warrick","year":"1998","journal-title":"Cell"},{"key":"2021112214193407900_B263","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1093\/hmg\/11.21.2657","article-title":"Suppression of polyglutamine toxicity by a Drosophila homolog of myeloid leukemia factor 1","volume":"11","author":"Kazemi-Esfarjani","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"2021112214193407900_B264","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/35040584","article-title":"Identification of genes that modify ataxin-1-induced neurodegeneration","volume":"408","author":"Fernandez-Funez","year":"2000","journal-title":"Nature"},{"key":"2021112214193407900_B265","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.molcel.2006.07.030","article-title":"MicroRNA pathways modulate polyglutamine-induced neurodegeneration","volume":"24","author":"Bilen","year":"2006","journal-title":"Mol. Cell"},{"key":"2021112214193407900_B266","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1176\/jnp.14.1.37","article-title":"Behavior in Huntington's disease: dissociating cognition-based and mood-based changes","volume":"14","author":"Thompson","year":"2002","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"2021112214193407900_B267","first-page":"168","article-title":"Huntington disease in Maryland: clinical aspects of racial variation","volume":"41","author":"Folstein","year":"1987","journal-title":"Am. J. Hum. Genet."},{"key":"2021112214193407900_B268","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000079953","article-title":"Suicide in Hungarian Huntington's disease patients","volume":"23","author":"Baliko","year":"2004","journal-title":"Neuroepidemiology"},{"key":"2021112214193407900_B269","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1176\/appi.ajp.158.5.799","article-title":"Cognitive correlates of obsessive and compulsive symptoms in Huntington's disease","volume":"158","author":"Anderson","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"2021112214193407900_B270","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1345\/aph.1C352","article-title":"Mirtazapine in suicidal Huntington's disease","volume":"37","author":"Bonelli","year":"2003","journal-title":"Ann. Pharmacother."},{"key":"2021112214193407900_B271","first-page":"216","article-title":"Obsessive compulsive disorder in Huntington disease: a case of isolated obsessions successfully treated with sertraline","volume":"15","author":"Patzold","year":"2002","journal-title":"Neuropsychiatry Neuropsychol. Behav. Neurol."},{"key":"2021112214193407900_B272","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1034\/j.1600-0404.2002.01197.x","article-title":"Olanzapine in Huntington's disease","volume":"105","author":"Paleacu","year":"2002","journal-title":"Acta Neurol. Scand."},{"key":"2021112214193407900_B273","first-page":"347","article-title":"Use of risperidone in psychosis associated with Huntington's disease","volume":"6","author":"Madhusoodanan","year":"1998","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"2021112214193407900_B274","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1055\/s-2003-815024","article-title":"Amisulpride in Huntington's disease","volume":"32","author":"Saft","year":"2005","journal-title":"Psychiatr. Prax."},{"key":"2021112214193407900_B275","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1176\/appi.psy.47.1.70","article-title":"Quetiapine in the treatment of behavioral disturbances in patients with Huntington's disease","volume":"47","author":"Alpay","year":"2006","journal-title":"Psychosomatics"},{"key":"2021112214193407900_B276","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1212\/01.wnl.0000198586.85250.13","article-title":"Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial","volume":"66","author":"Huntington Study Group","year":"2006","journal-title":"Neurology"},{"key":"2021112214193407900_B277","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/jnnp.63.1.35","article-title":"Clozapine versus placebo in Huntington's disease: a double blind randomised comparative study","volume":"63","author":"van\u00a0Vugt","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"2021112214193407900_B278","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00002826-200209000-00007","article-title":"Olanzapine for Huntington's disease: an open label study","volume":"25","author":"Bonelli","year":"2002","journal-title":"Clin. Neuropharmacol."},{"key":"2021112214193407900_B279","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/01.wnf.0000240945.44370.f0","article-title":"Two years' follow-up of rivastigmine treatment in Huntington disease","volume":"30","author":"de\u00a0Tommaso","year":"2007","journal-title":"Clin. Neuropharmacol."},{"key":"2021112214193407900_B280","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1212\/01.wnl.0000238106.10423.00","article-title":"Effect of donepezil on motor and cognitive function in Huntington disease","volume":"67","author":"Cubo","year":"2006","journal-title":"Neurology"},{"key":"2021112214193407900_B281","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neures.2005.06.021","article-title":"Clinico-pathological rescue of a model mouse of Huntington's disease by siRNA","volume":"53","author":"Wang","year":"2005","journal-title":"Neurosci. Res."},{"key":"2021112214193407900_B282","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/nm1076","article-title":"RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia","volume":"10","author":"Xia","year":"2004","journal-title":"Nat. Med."},{"key":"2021112214193407900_B283","doi-asserted-by":"crossref","first-page":"7195","DOI":"10.1073\/pnas.1231012100","article-title":"Allele-specific silencing of dominant disease genes","volume":"100","author":"Miller","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214193407900_B284","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/hmg\/ddi458","article-title":"Rapamycin alleviates toxicity of different aggregate-prone proteins","volume":"15","author":"Berger","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"2021112214193407900_B285","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0896-6273(00)80716-3","article-title":"Caspase-8 is required for cell death induced by expanded polyglutamine repeats","volume":"22","author":"Sanchez","year":"1999","journal-title":"Neuron"},{"key":"2021112214193407900_B286","doi-asserted-by":"crossref","first-page":"10483","DOI":"10.1073\/pnas.1832501100","article-title":"Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease","volume":"100","author":"Wang","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214193407900_B287","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/ana.10614","article-title":"Minocycline and doxycycline are not beneficial in a model of Huntington's disease","volume":"54","author":"Smith","year":"2003","journal-title":"Ann. Neurol."},{"key":"2021112214193407900_B288","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00004850-200411000-00004","article-title":"Neuroprotection in Huntington's disease: a 2-year study on minocycline","volume":"19","author":"Bonelli","year":"2004","journal-title":"Int. Clin. Psychopharmacol."},{"key":"2021112214193407900_B289","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/mds.20018","article-title":"Minocycline in Huntington's disease: a pilot study","volume":"19","author":"Thomas","year":"2004","journal-title":"Mov. Disord."},{"key":"2021112214193407900_B290","doi-asserted-by":"crossref","first-page":"14525","DOI":"10.1073\/pnas.0704482104","article-title":"Inhibitors of metabolism rescue cell death in Huntington's disease models","volume":"104","author":"Varma","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214193407900_B291","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1523\/JNEUROSCI.20-12-04389.2000","article-title":"Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease","volume":"20","author":"Ferrante","year":"2000","journal-title":"J. Neurosci."},{"key":"2021112214193407900_B292","doi-asserted-by":"crossref","first-page":"8942","DOI":"10.1523\/JNEUROSCI.22-20-08942.2002","article-title":"Therapeutic effects of cystamine in a murine model of Huntington's disease","volume":"22","author":"Dedeoglu","year":"2002","journal-title":"J. Neurosci."},{"key":"2021112214193407900_B293","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/mds.20756","article-title":"CYTE-I-HD: phase I dose finding and tolerability study of cysteamine (Cystagon) in Huntington's disease","volume":"21","author":"Dubinsky","year":"2006","journal-title":"Mov. Disord."},{"key":"2021112214193407900_B294","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/hmg\/10.12.1307","article-title":"Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington's disease","volume":"10","author":"Sittler","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"2021112214193407900_B295","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nm985","article-title":"Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease","volume":"10","author":"Tanaka","year":"2004","journal-title":"Nat. Med."},{"key":"2021112214193407900_B296","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1006\/mgme.2001.3156","article-title":"Long-term treatment with sodium phenylbutyrate in ornithine transcarbamylase-deficient patients","volume":"72","author":"Burlina","year":"2001","journal-title":"Mol. Genet. Metab."},{"key":"2021112214193407900_B297","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/mds.10229","article-title":"Riluzole prolongs survival time and alters nuclear inclusion formation in a transgenic mouse model of Huntington's disease","volume":"17","author":"Schiefer","year":"2002","journal-title":"Mov. Disord."},{"key":"2021112214193407900_B298","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1523\/JNEUROSCI.22-05-01592.2002","article-title":"Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease","volume":"22","author":"Ferrante","year":"2002","journal-title":"J. Neurosci."},{"key":"2021112214193407900_B299","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/archneur.60.7.996","article-title":"A randomized trial of amantadine in Huntington disease","volume":"60","author":"O'Suilleabhain","year":"2003","journal-title":"Arch. Neurol."},{"key":"2021112214193407900_B300","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1212\/01.WNL.0000096019.71649.2B","article-title":"Dosage effects of riluzole in Huntington's disease: a multicenter placebo-controlled study","volume":"61","author":"Huntington Study Group","year":"2003","journal-title":"Neurology"},{"key":"2021112214193407900_B301","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1212\/WNL.53.5.1000","article-title":"Influence of lamotrigine on progression of early Huntington disease: a randomized clinical trial","volume":"53","author":"Kremer","year":"1999","journal-title":"Neurology"},{"key":"2021112214193407900_B302","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1212\/WNL.57.3.397","article-title":"A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease","volume":"57","author":"Huntington Study Group","year":"2001","journal-title":"Neurology"},{"key":"2021112214193407900_B303","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1006\/exnr.1998.6926","article-title":"Striatal transplantation in a transgenic mouse model of Huntington's disease","volume":"154","author":"Dunnett","year":"1998","journal-title":"Exp. Neurol."},{"key":"2021112214193407900_B304","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0361-9230(01)00655-4","article-title":"Anterior cingulate cortical transplantation in transgenic Huntington's disease mice","volume":"56","author":"van\u00a0Dellen","year":"2001","journal-title":"Brain Res. Bull."},{"key":"2021112214193407900_B305","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000098976","article-title":"Stereotactic technique and pathophysiological mechanisms of neurotransplantation in Huntington's chorea","volume":"58","author":"Sramka","year":"1992","journal-title":"Stereotact. Funct. Neurosurg."},{"key":"2021112214193407900_B306","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/01616412.1995.11740334","article-title":"Fetal striatal homotransplantation for Huntington's disease: first two case reports","volume":"17","author":"Madrazo","year":"1995","journal-title":"Neurol. Res."},{"key":"2021112214193407900_B307","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/exnr.1997.6685","article-title":"Safety of intrastriatal neurotransplantation for Huntington's disease patients","volume":"149","author":"Kopyov","year":"1998","journal-title":"Exp. Neurol."},{"key":"2021112214193407900_B308","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1006\/exnr.1999.7239","article-title":"Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington's disease","volume":"161","author":"Bachoud-Levi","year":"2000","journal-title":"Exp. Neurol."},{"key":"2021112214193407900_B309","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1136\/jnnp.73.6.678","article-title":"Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report ISRCTN no. 36485475","volume":"73","author":"Rosser","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"2021112214193407900_B310","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1212\/WNL.54.5.1042","article-title":"Transplantation of embryonic porcine mesencephalic tissue in patients with PD","volume":"54","author":"Schumacher","year":"2000","journal-title":"Neurology"},{"key":"2021112214193407900_B311","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1212\/WNL.58.5.687","article-title":"Bilateral human fetal striatal transplantation in Huntington's disease","volume":"58","author":"Hauser","year":"2002","journal-title":"Neurology"},{"key":"2021112214193407900_B312","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/brain\/awh003","article-title":"Striatal neural grafting improves cortical metabolism in Huntington's disease patients","volume":"127","author":"Gaura","year":"2004","journal-title":"Brain"},{"key":"2021112214193407900_B313","doi-asserted-by":"crossref","first-page":"13877","DOI":"10.1073\/pnas.97.25.13877","article-title":"Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology","volume":"97","author":"Freeman","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214193407900_B314","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1177\/096368970000900507","article-title":"Neurotrophic factors NGF and FGF-2 alter levels of huntingtin (IT15) in striatal neuronal cell cultures","volume":"9","author":"Haque","year":"2000","journal-title":"Cell Transplant."},{"key":"2021112214193407900_B315","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1089\/10430340050015220","article-title":"Restoration of cognitive and motor functions by ciliary neurotrophic factor in a primate model of Huntington's disease","volume":"11","author":"Mittoux","year":"2000","journal-title":"Hum. Gene Ther."},{"key":"2021112214193407900_B316","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1089\/hum.2004.15.968","article-title":"Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I study","volume":"15","author":"Bloch","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"2021112214193407900_B317","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/brain\/awl027","article-title":"Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles","volume":"129","author":"Underwood","year":"2006","journal-title":"Brain"}],"container-title":["Biochemical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/biochemj\/article-pdf\/412\/2\/191\/655366\/bj4120191.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/biochemj\/article-pdf\/412\/2\/191\/655366\/bj4120191.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T17:24:54Z","timestamp":1637601894000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/biochemj\/article\/412\/2\/191\/44880\/Huntington-s-disease-from-pathology-and-genetics"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,14]]},"references-count":317,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,6,1]]}},"URL":"https:\/\/doi.org\/10.1042\/bj20071619","relation":{},"ISSN":["0264-6021","1470-8728"],"issn-type":[{"value":"0264-6021","type":"print"},{"value":"1470-8728","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,14]]}}}